๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Therapeutic apheresis in renal and metabolic diseases

โœ Scribed by Jeffrey L. Winters; Alvaro A. Pineda; Bruce C. McLeod; Kathleen M. Grima

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
122 KB
Volume
15
Category
Article
ISSN
0733-2459

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

An overview of therapeutic apheresis in
An overview of therapeutic apheresis in pediatrics
โœ Dolores M. Galacki ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 22 KB ๐Ÿ‘ 1 views

Therapeutic apheresis in pediatrics requires selected modifications due to the child's smaller size, blood volume, and developmental age. Red blood cell priming is used to prevent dilution of the child's hematocrit from the normal saline prime. Continuous flow cell separators maintain isovolemia. Di

Phytanic acid storage disease (Refsum's
Phytanic acid storage disease (Refsum's disease): Clinical characteristics, pathophysiology and the role of therapeutic apheresis in its management
โœ Robert Weinstein ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 26 KB ๐Ÿ‘ 1 views

Phytanic acid storage disease (known also as Refsum's Disease) is caused by inherited defects in the metabolic pathway for phytanic acid, a dietary branched-chain fatty acid. Poorly metabolized phytanic acid accumulates in fatty tissues, including myelin sheaths, and in organs including the liver an